英文名称 | CAS号 | 中文名 | 中文别名 | 分子式 | 分子量 | EINECS号 |
---|---|---|---|---|---|---|
Nefiracetam
|
77191-36-7 |
奈非西坦
|
N-(2,6-二甲基苯基)-2-氧-1-吡咯啉羧酰胺;尼非西坦;N-(2,6-二甲基苯基)-2-氧代-1-吡咯烷乙酰胺;奈非西坦;萘非西坦;奈菲西坦
|
C14H18N2O2 |
246.30492 | 636-080-4 |
NAFAMOSTAT MESYLATE
|
81525-10-2 |
萘莫司他
|
萘莫司他;4-胍基苯甲酸6-脒基-2-萘酯;NAFAMOSTAT 甲磺酸盐;苯甲酸,4-[(氨基亚氨基甲基)氨基]-,6-(氨基亚氨基甲基)-3-萘基 酯
|
C21H25N5O8S2 |
539.58 | 1806241-263-5 |
MPEP
|
96206-92-7 |
MPEP
|
2-甲基-6-(苯乙炔)吡啶盐酸盐;2-甲基-6-(苯基乙炔基)吡啶;CS-715;MPEP 100MG
|
C14H11N.HCl |
229.70478 | |
MK-0974 (Telcagepant)
|
781649-09-0 |
N-[(3R,6S)-6-(2,3-二氟苯基)六氢-2-氧代-1-(2,2,2-三氟乙基)-1H-氮杂卓-3-基]-4-(2,3-二氢-2-氧代-1H-咪唑并[4,5-B]吡啶-1-基)-1-哌啶甲酰胺
|
N-[(3R,6S)-6-(2,3-二氟苯基)六氢-2-氧代-1-(2,2,2-三氟乙基)-1H-氮杂卓-3-基]-4-(2,3-二氢-2-氧代-1H-咪唑并[4,5-B]吡啶-1-基)-1-哌啶甲酰胺;CS-454;TELCAGEPANT;MK0974;MK 0974
|
C26H27F5N6O3 |
566.52 | |
Mitoxantrone
|
65271-80-9 |
米托蒽醌
|
米托恩醌;盐酸米托蒽醌 ;1,4-二羟基-5,8-二[[2-[(2-羟基乙基)氨基]乙基]氨基]蒽-9,10-二酮;米拖蒽醌;米托蒽醌(米托恩醌、米拖蒽醌);米托蒽醌;1,8-双[[2-[(2-羟乙基)氨基]乙基]氨基]-9,11-蒽醌
|
C22H28N4O6 |
444.48 | 1533716-785-6 |
17a-Ethynyl-1,3,5(10)-estratriene-3,17b-diol 3-methyl ether
|
72-33-3 |
美雌醇
|
17Α-乙炔雌二醇 3-甲醚;17Α-乙炔基-1,3,5(10)-雌三烯-3,17Β-二醇 3-甲醚;3-甲氧基-17Α-乙炔雌二醇;乙炔雌二醇 3-甲醚;(8R,9S,13S,14S)-17-乙炔基-3-甲氧基-13-甲基-7,8,9,11,12,14,15,16-八氢-6H-环戊烷并[A]菲-17-醇;17-乙炔基-3-甲氧基雌二醇-1(10),2,4-三烯-17-醇;美雌醇 标准品;炔雌醇甲醚
|
C21H26O2 |
310.44 | 200-777-8 |
Meclofenoxate hydrochloride
|
3685-84-5 |
盐酸甲氯芬酯
|
盐酸氯酯醒;3-(二甲基氨基)乙基对氯苯氧基乙酸酯盐酸盐;氯醒酯;盐酸甲氯芬酯;盐酸甲氯酚酯;甲硝唑磷酸二钠(无菌粉);MECLOFENOXATE HCL 盐酸甲氯酚酯;酸甲氯芬酯
|
C12H16CLNO3.HCL;C12H17CL2NO3 |
294.18 | 222-975-3 |
MAC13243
|
1071638-38-4 |
MAC 13243
|
|
C20H25Cl2N3O2S |
442.4024 | |
LY335979 (Zosuquidar tri hydrochloride)
|
167465-36-3 |
唑喹达三盐酸盐
|
RS-33295-198;ZOSUQUIDAR;LY-335979;CS-58;唑喹达三盐酸盐;ZOSUQUIDAR 三盐酸盐;(2R)-1-{4-[(1AR,6R,10BS)-1,1-二氟-1,1A,6,10B-四氢二苯并[A,E]环丙并[C]环庚烯-6-基]哌嗪-1-基}-3-(喹啉-5-基氧基)丙-2-醇三盐酸盐;RS-33295-198,ZOSUQUIDAR;唑喹达盐酸盐
|
C32H31F2N3O2.3(HCl) |
636.99 | |
LITHOCHOLIC ACID
|
434-13-9 |
石胆酸
|
石胆酸;胆石酸;3Α-羥膽烷酸;石膽酸;3Α-烷酸;石酸;3-羟基胆基酸;石胆甾酸
|
C24H40O3 |
376.57 | 207-099-1 |
LCQ-908
|
956136-95-1 |
LCQ-908
|
|
C25H24F3N3O2 |
455.47217 | |
Laropiprant
|
571170-77-9 |
LAROPIPRANT
|
拉罗皮兰;(R)-2-(4-(4-氯苄基)-7-氟-5-(甲基磺酰基)-1,2,3,4-四氢环戊烷并[B]吲哚-3-基)乙酸;MK0524;LAROPIPRANT;MK-0524;各拉西酮;拉罗皮兰,MK0524;拉罗匹仑;CS-624
|
C21H19ClFNO4S |
435.901 | 682-424-1 |
Kauniolide
|
81066-45-7 |
KAUNIOLIDE
|
CS-1319
|
C15H18O2 |
230.3 | |
JZL195
|
1210004-12-8 |
JZL-195
|
JZL-195;JZL 195;JZL195;CS-1586
|
C24H23N3O5 |
433.45652 | |
JIB-04
|
199596-05-9 |
5-氯-2(1H)-吡啶酮 (2E)-(苯基-2-吡啶基亚甲基)腙
|
5-氯-2(1H)-吡啶酮 (2E)-(苯基-2-吡啶基亚甲基)腙>97%;CS-1447;NSC693627;JIB04;JIB 04;NSC-693627;JIB-04;JIB04;5-氯-2(1H)-吡啶酮 (2E)-(苯基-2-吡啶基亚甲基)腙;(E)-5-CHLORO-2-(2-(PHENYL(PYRIDIN-2-YL)METHYLENE)HYDRAZINYL)PYRIDINE
|
C17H13ClN4 |
308.76492 | |
Isoliquiritigenin
|
961-29-5 |
异甘草素
|
异甘草素对照品;异甘草素(标准品);异甘草苷元,4,2',4'-三羟基查耳酮,4'-三羟基查耳酮;异甘草素98%;异甘草素(异甘草苷元,4'-三羟基查耳酮);ISOLIQUIRITIGENIN 异甘草素;4'-三羟基查耳酮;4'-三羟基查耳酮)
|
C15H12O4 |
256.25 | |
IPI-145
|
1201438-56-3 |
IPI-145
|
8-氯-2-苯基-3-[(1S)-1-(7H-嘌呤-6-基氨基)乙基]异喹啉1-1;IPI145;IPI 145;IPI-145. INK-1197;INK 1197;INK1197;DUVELISIB (IPI-145;INK1197);IPI-145 INK197;DUVELISIB (IPI-145);IPI-145 INK197;DUVELISIB (IPI-145);DUVELISIB (IPI-145,INK1197);IPI 145;IPI145;度维利塞;(S)-3-(1-((9H-嘌呤-6-基)氨基)乙基)-8-氯-2-苯基-1(2H)-异喹啉酮
|
C22H16ClN6O |
415.85504 | 200-256-5 |
GSK2636771
|
1372540-25-4 |
GSK2636771
|
CS-357;2-甲基-1-[[2-甲基-3-(三氟甲基)苯基]甲基]-6-(4-吗啉基)-1H-苯并咪唑-4-羧酸
|
C22H22F3N3O3 |
433.42 | |
Homoharringtonine
|
26833-87-4 |
高三尖杉酯碱
|
高三尖杉酯碱(高粗榧碱;高俣林通碱);高三尖杉酯碱(高粗榧碱,后哈莫林通碱,高俣林通碱);高粗榧碱;后哈莫林通碱;HOMOHARRINGTONINE 高三尖杉酯碱;OMACETAXINE MEPESUCCINATE;HHT;OMAPRO OMACETAXINE MEPESUCCINATE
|
C29H39NO9 |
545.62 | |
GSK 2334470
|
1227911-45-6 |
GSK2334470
|
1S,4R)-3-(6-(3-AMINO-1H-INDAZOL-6-YL)-2-(METHYLAMINO)PYRIMIDIN-4-YL)-N-CYCLOHEXYL-4-METHYLCYCLOHEXAN;CS-1873;GSK2334470;GSK 2334470;GSK-2334470
|
C25H34N8O |
462.59046 |